| 0 (0%) | 10-15 12:16 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 280.34 | 1-year : | 288.98 |
| Resists | First : | 240.02 | Second : | 247.41 |
| Pivot price | 236.64 |
|||
| Supports | First : | 228.05 | Second : | 189.73 |
| MAs | MA(5) : | 233.84  |
MA(20) : | 236.32 |
| MA(100) : | 232.91 |
MA(250) : | 219.05 |
|
| MACD | MACD : | 0 |
Signal : | 0.7 |
| %K %D | K(14,3) : | 32.1 |
D(3) : | 25.4 |
| RSI | RSI(14): 50.6 |
|||
| 52-week | High : | 260.83 | Low : | 184.75 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ ALX ] has closed above bottom band by 47.5%. Bollinger Bands are 38.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 233.98 - 234.88 | 234.88 - 235.91 |
| Low: | 225.6 - 226.57 | 226.57 - 227.68 |
| Close: | 231.15 - 232.72 | 232.72 - 234.52 |
Wed, 15 Oct 2025
Key metrics from ALX Oncology Holdings Inc.’s quarterly data - 2025 Major Catalysts & Verified High Yield Trade Plans - newser.com
Tue, 14 Oct 2025
Key metrics from ALX Oncology Holdings Inc.’s quarterly data - July 2025 PostEarnings & High Return Trade Opportunity Guides - newser.com
Mon, 13 Oct 2025
ALX Pink Weekend, celebrating 10 years of lasting impact - DC News Now
Mon, 13 Oct 2025
ALX Pink Weekend marks a decade of raising breast cancer awareness - WJLA
Sat, 11 Oct 2025
ALX Uranium, Ore Uranium, Uranium SA: 2025 Mining Innovations - Farmonaut
Wed, 01 Oct 2025
Alexandria Debuts First-Ever ‘State of Arts ALX’ - thezebra.org
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 5 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 58.3 (%) |
| Held by Institutions | 32.5 (%) |
| Shares Short | 176 (K) |
| Shares Short P.Month | 166 (K) |
| EPS | 7.28 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 28.47 |
| Profit Margin | 17.1 % |
| Operating Margin | 29 % |
| Return on Assets (ttm) | 3.2 % |
| Return on Equity (ttm) | 20.8 % |
| Qtrly Rev. Growth | -3.5 % |
| Gross Profit (p.s.) | 22.23 |
| Sales Per Share | 42.67 |
| EBITDA (p.s.) | 20.97 |
| Qtrly Earnings Growth | -27 % |
| Operating Cash Flow | 85 (M) |
| Levered Free Cash Flow | 92 (M) |
| PE Ratio | 32.45 |
| PEG Ratio | 0 |
| Price to Book value | 8.29 |
| Price to Sales | 5.53 |
| Price to Cash Flow | 14.19 |
| Dividend | 4.5 |
| Forward Dividend | 0 |
| Dividend Yield | 1.9% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|